Atrys Health, S.A. Enterprise Value to EBITDA (EV/EBITDA) on July 28, 2025: 20.37

Atrys Health, S.A. Enterprise Value to EBITDA (EV/EBITDA) is 20.37 on July 28, 2025, a 15.85% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Atrys Health, S.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 21.02 on July 28, 2025, which is 3.22% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Atrys Health, S.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 16.20 on July 28, 2025, which is -20.46% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Atrys Health, S.A. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 18.01.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization